Tagged with S

Singapore Singapore is far ahead of its Asia-Pacific peers in terms of GDP per person. Made with Visme Infographic Maker   Singapore was ranked Asia-Pacific’s, and indeed the world’s, most competitive country/region for 2019. Made with Visme Infographic Maker   Singapore also performs well on the world digital ranking, sitting behind only the…

China PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the company’s focus on DNA-encoded chemical libraries (DEL) and their multipronged business strategy. Established in 2012, the company introduced the novel DEL technology platform to China.   As Dr Li recounted, “it was not…

Global Epidemiologist John-Arne Røttingen has had a long and distinguished career in both academia and industry, including stints at Oslo, Oxford and Harvard universities, as well as helping coordinate the WHO’s response to the West African Ebola virus epidemic of 2013-2016 and being the founding CEO of the Coalition for Epidemic…

Norway CEO Ellen Cathrine Andersen introduces Norwegian firm Epiguard’s ‘Epishuttle’ technology for transporting highly contagious patients, the crucial role that the product is playing in helping to tackle the COVID-19 pandemic across the world, and where she hopes to take the company moving forward.   We have now sold the Epishuttle…

Global Sanofi CEO Paul Hudson ignited a heated debate around vaccine nationalism earlier this year when he suggested that the US, having made the biggest initial investment in Sanofi’s COVID-19 vaccine development, should have the first call on any vaccine that the firm was subsequently able to bring to market. In…

Global During the FT Global Pharmaceutical and Biotechnology Conference last week, GSK global vaccines president Roger Connor shared some of his insights regarding the reorganization of GSK’s Consumer Health, Pharmaceuticals and Vaccines business units, their pandemic adjuvant system technology, and their – and the industry’s overall – commitment to COVID-19 vaccine…

Global Ipsen CEO David Loew took aim at the lip service often paid to the notion of ‘patient-centricity’ in pharma in conversation at the FT’s Global Pharmaceutical and Biotechnology Conference last week and explained how the industry should take on a wider and deeper role in shaping healthcare systems, thereby creating…

USA David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term sustainability.   The life sciences industry within the United States makes significant contributions to both America’s health and economy and is a leader in R&D and innovation based on numerous proxies including patents received,…

Canada Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its current legal status, provincial variations in patient registrations, financial performance, the impact of COVID-19, and where the field is headed for the future.   The cannabis plant has been used as a…

Switzerland PharmaBoardroom highlights three of the most enterprising and dynamic pharma affiliate country managers working in Switzerland today and their strategies for success in one of the world’s most innovative nations.   Henrik Asmussen, General Manager, Amgen Switzerland   Danish national Henrik Asmussen, head of Amgen Switzerland since 2017, outlined the…

Asia-Pacific The latest from Southeast Asian pharma, including soaring output in Singapore, tax breaks for research in Indonesia, Thai firm Factorytalk’s UK expansion, and the potential for a Russian COVID-19 vaccine manufacturing facility in the Philippines.   Singapore Factory Output Surges At Fastest Pace In Nine Years On Pharma Boost (Business…

Global Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park highlights key takeaways from the BIOJapan 2020 conference on why San Diego offers a good example of what it takes to be a leader in the innovative life science sector.   Over the past two decades, drug discovery has undergone…